Sign inJoin waitlistJoin the waitlist

Richard Formica

Director of Transplant Medicine, Internal Medicine · Yale School of Medicine

Credentials: · · · ·

History

Transplantation Center · Yale-New Haven Hospital
Present
Transplantation Center · Yale-New Haven Hospital
Present
Yale School of Medicine
Present

Nephrology
Yale School of Medicine
1998–1999
Surgery
Yale-New Haven Hospital
1993–1998
Internal Medicine
Boston University Medical Center
Chief ResidentUntil 1997
1993–1996
Boston University School of Medicine
1989–1993
Boston University
1986–1989
Boston University
1989

Research

Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis
Systematic review or meta-analysis · Nephrology · 2009 · 612 citations
New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes
Journal of the American Society of Nephrology · 2014 · 331 citations
The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation
American Journal of Transplantation · 2017 · 259 citations

Sanjay Kulkarni
19 papers · 2 as a resident
MB
Margaret Bia
10 papers
John Friedewald
9 papers
Bohdan Pomahac
8 papers · 8 as a resident
David Mulligan
8 papers · 4 as a fellow
Kenneth Newell
8 papers
William Asch
8 papers
ML
Marc Lorber
7 papers
MK
Martin Kauke-Navarro
7 papers · 7 as a resident
AF
Amy Friedman
6 papers
Emilio Poggio
6 papers
Madhav Menon
6 papers

Clinical trials

Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.
Principal investigator · Completed · Early phase 1
Yale University
2018–2024
Noninvasive Methods to Monitor Graft Survival in Kidney Transplant Patients
Principal investigator · Completed
National Institute of Allergy and Infectious Diseases (NIAID)
2006–2011
Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation
Site PI · Recruiting · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2023–2029